Rao Kalla

Rao Kalla

Gilead Sciences Inc. - California / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4389790
-
person_outline Rao Kalla's MOST POPULAR ARTICLES
1-) Catalytic amination of 2-substituted pyridines with hydrazine derivativesJB Arterburn, KV Rao, R Ramdas, BR DibleOrganic letters 3 (9), 1351-1354, 20011012001
2-) Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonistsM Yang, D Soohoo, S Soelaiman, R Kalla, J Zablocki, N Chu, K Leung, ...Naunyn-Schmiedeberg\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'s archives of pharmacology 375 (2), 133-144, 2007852007
3-) Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferretsRM Cox, JD Wolf, CM Lieber, J Sourimant, MJ Lin, D Babusis, V DuPont, ...Nature Communications 12 (1), 6415, 2021852021
4-) Novel 1,3-Disubstituted 8-(1-benzyl-1H-pyrazol-4-yl) Xanthines:  High Affinity and Selective A2B Adenosine Receptor AntagonistsRV Kalla, E Elzein, T Perry, X Li, V Palle, V Varkhedkar, A Gimbel, T Maa, ...Journal of medicinal chemistry 49 (12), 3682-3692, 2006832006
5-) Discovery of a Novel A2B Adenosine Receptor Antagonist as a Clinical Candidate for Chronic Inflammatory Airway DiseasesE Elzein, RV Kalla, X Li, T Perry, A Gimbel, D Zeng, D Lustig, K Leung, ...Journal of medicinal chemistry 51 (7), 2267-2278, 2008812008